The sequence repeats itself in clinics across India. A blood sugar reading is taken, a prescription is printed, and the patient is sent home with one number to manage. Years later the same person returns with a kidney that is quietly failing, a foot ulcer that will not close, or a heart under strain — none of which was ever part of the original conversation.
The gap between a single diagnosis and a cluster of risks is why a growing number of doctors and public health researchers argue that India needs a different model of diabetes care — built around complications and continuity, not a test result.
One Diagnosis, Several Diseases in Waiting
Diabetes is a condition of blood sugar, but it behaves like a disease of blood vessels and nerves. Persistently high glucose damages small vessels in the kidney and retina, larger vessels feeding the heart and brain, and nerves in the feet that signal injury too late.
The consequence is that a person with diabetes is rarely managing one condition. They are managing several parallel risks — some silent for a decade. In India's care structure each risk usually belongs to a different specialist, in a different building, on a different appointment date.
Why a Single-Specialist Visit Is No Longer Enough
The economics of that structure fall on the patient. One clinic visit covers glucose. A separate trip covers the eye. Another covers the kidney. A fourth covers the foot, and only after a wound has already become an emergency.
Every additional appointment costs money, travel and a day's wages. The result is predictable: the check that feels least urgent gets postponed, and the complication that was cheapest to prevent becomes the most expensive to treat.
How India's Diabetes Care Took This Shape
India's diabetes response grew largely through episodic, urban and private-sector care, where a physician consultation is short, prescriptions are written outside the room, and records stay with the patient. The public system built its own layer through the national programme for non-communicable diseases, now delivered via the health and wellness centre network.
That network expanded screening considerably. What it has struggled to guarantee is the second, third and fourth visit — the part where risk is tracked over years rather than confirmed once.
The Bill That Arrives Beyond Insulin
For most Indian households, the visible cost of diabetes is medicine. The real cost sits elsewhere: dialysis sessions, laser treatment for the eye, vascular surgery, and amputations that end a working life.
These costs are not borne by the patient alone. They are absorbed by families, often across generations, and they arrive years after the diagnosis when the household has already stopped treating the condition as new.
What Health Institutions and Researchers Are Pointing To
National estimates widely cited by researchers place the number of Indians living with diabetes above 100 million, with a comparable population in the prediabetes range — figures drawn from large-scale survey work published by Indian investigators in recent years.
Public health bodies frame diabetes within the broader non-communicable disease burden, alongside hypertension and cardiovascular risk. That framing matters: it argues for combined screening and combined management rather than a standalone diabetes vertical.
The Case for Complications-First Care
The alternative being discussed is unglamorous and largely logistical. A single visit that includes a urine test for kidney protein, a retinal check, a foot examination and a blood pressure reading — completed in one room, recorded once, repeated on schedule.
It also means task-shifting. Nurses and community health workers can handle measurements, foot checks and follow-up reminders, leaving physicians for decisions rather than data collection. Digital records make that possible; weak record systems are what have held it back.
What Is Established — and What Still Isn't
Established: diabetes carries elevated lifetime risk of kidney, eye, nerve and cardiovascular damage; early detection of those complications improves outcomes; India's primary care network has the reach to screen at scale.
Not established: which model of integrated care works at Indian population scale, what it costs per patient, and whether state budgets and insurance design can absorb it. Exact prevalence figures also vary by survey method, region and diagnostic criteria — reported estimates should be read as ranges, not settled counts. The opening clinic scenario in this piece is illustrative, not a documented case.
The Trade-offs a New Model Would Have to Admit
Integrated care is not automatically better care. Bundled screening can generate over-testing, unnecessary referrals and anxiety in people whose risk is low. It can also create a quiet commercial incentive to convert screening into lifelong treatment packages.
There is a workforce problem too. A nurse-led model only works if nurses are available, trained and not already carrying a dozen other responsibilities. And digital follow-up assumes a smartphone, connectivity and literacy that many patients still do not have.
From a Diabetes Programme to an NCD Programme
The deeper shift is conceptual. India's health system has spent two decades building disease-specific programmes, each with its own register, target and reporting format. Its actual patients now arrive with two or three conditions at once.
Diabetes is the clearest test case for that mismatch. Ageing, urbanisation and changing diets are pushing multimorbidity into younger age groups, which means the cost of fragmented care will rise faster than the number of new cases.
What Patients and Families Can Do Differently
Ask for the checks that do not come with a symptom. A yearly eye examination, a urine protein test, a foot inspection and a blood pressure reading should be treated as routine parts of a diabetes review, not extras.
Keep one notebook or one digital file with every reading and prescription, so each doctor sees the same history. And when a new specialist is added, tell them what else is already being treated — fragmentation usually starts with information that was never passed on.
What the Next Five Years Could Look Like
Expect more pilot programmes combining kidney, eye and foot screening at the primary level, and more experimentation with nurse-led follow-up. Whether those pilots consolidate into a national standard is a policy question, not a clinical one.
Without a records backbone and a financing model that pays for prevention rather than procedures, integrated care will likely remain a well-designed exception rather than the default.
Our Take
India's diabetes problem is usually discussed as a numbers problem — how many millions, how fast the curve is rising. The harder and more useful question is structural: a system designed to confirm a diagnosis is being asked to prevent a decade of consequences.
A new model does not require new science. It requires that four checks happen in one room, that the result is written down once, and that someone is accountable for the next visit. That is less exciting than a breakthrough, and considerably more likely to change outcomes.
Frequently Asked Questions
Why is a single prescription not enough for diabetes?
Because diabetes damages blood vessels and nerves over years, affecting the kidneys, eyes, feet, heart and brain. A prescription addresses blood sugar; it does not by itself detect or prevent those complications, which need periodic screening.
Which complications should people with diabetes be screened for routinely?
Kidney damage (through a urine protein test and kidney function blood test), retinal damage (through an eye examination), nerve and foot problems (through a foot inspection), and cardiovascular risk (through blood pressure and lipid checks).
What is meant by integrated diabetes care?
It means combining these checks into one coordinated visit or care cycle, with shared records and a named point of follow-up — instead of sending the patient to separate specialists at separate times.
Does India already have a diabetes programme?
Yes. Diabetes is covered under the national programme for prevention and control of non-communicable diseases, delivered through primary care and health and wellness centres. The gap being debated is long-term follow-up and complication management, not basic screening reach.